NYSE:PFE - Pfizer Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $39.79
  • Forecasted Upside: 4.22 %
  • Number of Analysts: 13
  • Breakdown:
  • 0 Sell Ratings
  • 8 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$38.18
▲ +0.75 (2.00%)
1 month | 3 months | 12 months
Get New Pfizer Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PFE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PFE

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$39.79
▲ +4.22% Upside Potential
This price target is based on 13 analysts offering 12 month price targets for Pfizer in the last 3 months. The average price target is $39.79, with a high forecast of $53.00 and a low forecast of $24.00. The average price target represents a 4.22% upside from the last price of $38.18.
Hold
The current consensus among 13 investment analysts is to hold stock in Pfizer.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 4 buy ratings
  • 16 hold ratings
  • 0 sell ratings
5/2/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 15 hold ratings
  • 0 sell ratings
7/31/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 11 hold ratings
  • 0 sell ratings
10/29/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 8 hold ratings
  • 0 sell ratings
1/27/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 7 hold ratings
  • 0 sell ratings
4/26/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 8 hold ratings
  • 0 sell ratings
7/25/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 7 hold ratings
  • 0 sell ratings
9/23/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 8 hold ratings
  • 0 sell ratings
10/23/2020

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 8 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/23/2020TruistInitiated CoverageBuy$42.00Low
i
10/16/2020Royal Bank of CanadaSet Price TargetBuy$43.00Low
i
10/12/2020Atlantic SecuritiesDowngradeOverweight ➝ Neutral$44.00 ➝ $39.00Low
i
9/29/2020Berenberg BankInitiated CoverageHold$38.00Low
i
9/15/2020MizuhoReiterated RatingBuy$43.00Low
i
Rating by Vamil Divan at Mizuho
9/9/2020Royal Bank of CanadaSet Price TargetBuy$43.00Low
i
7/30/2020Morgan StanleyBoost Price TargetEqual Weight$36.00 ➝ $42.00Low
i
Rating by David Risinger at Morgan Stanley
7/29/2020UBS GroupBoost Price TargetNeutral$37.00 ➝ $39.00Low
i
7/29/2020SVB LeerinkBoost Price TargetMarket Perform$39.00 ➝ $42.00Low
i
Rating by G. Porges at SVB Leerink LLC
7/28/2020MizuhoReiterated RatingPositive ➝ Buy$38.00Low
i
Rating by Vamil Divan at Mizuho
7/21/2020Morgan StanleyReiterated RatingHold$36.00High
i
Rating by David Risinger at Morgan Stanley
7/20/2020Royal Bank of CanadaReiterated RatingBuy$43.00High
i
6/29/2020MizuhoInitiated CoverageBuy$38.00Low
i
Rating by Vamil Divan at Mizuho
6/26/2020Piper SandlerBoost Price Target$18.50 ➝ $24.00Medium
i
6/16/2020SVB LeerinkInitiated CoverageMarket Perform$40.00Low
i
Rating by G. Porges at SVB Leerink LLC
6/1/2020BarclaysLower Price Target$37.00 ➝ $35.00Medium
i
6/1/2020JPMorgan Chase & Co.Lower Price TargetNeutral$37.00 ➝ $36.00High
i
5/18/2020MizuhoReiterated RatingBuy$42.00Low
i
Rating by Vamil Divan at Mizuho
4/29/2020BarclaysBoost Price TargetEqual Weight$36.00 ➝ $37.00Low
i
4/27/2020Royal Bank of CanadaReiterated RatingBuy$44.00Medium
i
4/26/2020MizuhoReiterated RatingBuy$42.00High
i
Rating by Vamil Divan at Mizuho
4/2/2020Morgan StanleyLower Price TargetEqual Weight$43.00 ➝ $36.00Medium
i
3/27/2020Royal Bank of CanadaLower Price TargetOutperform$46.00 ➝ $44.00Low
i
3/19/2020Cantor FitzgeraldReiterated RatingBuy$53.00High
i
Rating by Louise Chen at Cantor Fitzgerald
3/18/2020MizuhoReiterated RatingBuy$42.00High
i
Rating by Vamil Divan at Mizuho
2/27/2020Standpoint ResearchUpgradeHold ➝ BuyHigh
i
2/27/2020BarclaysInitiated CoverageEqual Weight$36.00Medium
i
2/5/2020MizuhoInitiated CoverageBuy$42.00Low
i
1/29/2020Cantor FitzgeraldReiterated RatingBuy$53.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
1/28/2020JPMorgan Chase & Co.Reiterated RatingNeutral$37.00Low
i
1/6/2020Royal Bank of CanadaInitiated CoverageOutperform$46.00Medium
i
11/6/2019Credit Suisse GroupReiterated RatingHold$41.30Low
i
10/29/2019JPMorgan Chase & Co.Reiterated RatingNeutralHigh
i
Rating by Chris Schott at JPMorgan Chase & Co.
10/16/2019Bank of AmericaInitiated CoverageNeutral$37.00Low
i
9/19/2019JPMorgan Chase & Co.Boost Price TargetNeutral$37.00 ➝ $46.00Low
i
Rating by Chris Schott at JPMorgan Chase & Co.
8/28/2019DZ BankUpgradeSell ➝ Hold$36.00Medium
i
8/27/2019Morgan StanleyLower Price TargetEqual Weight$40.00 ➝ $38.00High
i
8/27/2019DZ BankReiterated RatingHold ➝ NeutralMedium
i
8/12/2019Credit Suisse GroupReiterated RatingHold ➝ NeutralHigh
i
8/5/2019UBS GroupReiterated RatingNeutral$43.00High
i
7/30/2019Bank of AmericaDowngradeBuy ➝ NeutralHigh
i
7/30/2019Morgan StanleyDowngradeOverweight ➝ Equal Weight$48.00 ➝ $40.00High
i
7/29/2019JPMorgan Chase & Co.Set Price TargetNeutral$46.00High
i
Rating by Chris Schott at JPMorgan Chase & Co.
7/23/2019JPMorgan Chase & Co.Reiterated RatingNeutral$46.00Low
i
Rating by Chris Schott at JPMorgan Chase & Co.
7/15/2019Credit Suisse GroupInitiated CoverageHold$47.00Low
i
6/17/2019Credit Suisse GroupReiterated RatingBuy$48.00Low
i
6/17/2019Goldman Sachs GroupReiterated RatingBuy$49.00Low
i
6/17/2019JPMorgan Chase & Co.Reiterated RatingHold$46.00Low
i
6/4/2019Morgan StanleyInitiated CoverageOverweight ➝ Overweight$48.00Low
i
5/28/2019Goldman Sachs GroupInitiated CoverageConviction-BuyLow
i
5/9/2019BarclaysReiterated RatingHold$41.00Low
i
5/6/2019Credit Suisse GroupReiterated RatingBuy$48.00Medium
i
Rating by Vamil Divan at Credit Suisse Group AG
4/30/2019JPMorgan Chase & Co.Set Price TargetNeutral$46.00Low
i
Rating by Chris Schott at JPMorgan Chase & Co.
4/19/2019JPMorgan Chase & Co.Reiterated RatingNeutral$46.00N/A
i
Rating by Chris Schott at JPMorgan Chase & Co.
4/1/2019Bank of AmericaBoost Price TargetBuy ➝ Buy$45.00 ➝ $48.00Low
i
2/20/2019CitigroupReiterated RatingSell ➝ Neutral$41.00Medium
i
Rating by Andrew Baum at Citigroup Inc.
2/19/2019Cantor FitzgeraldReiterated RatingBuy$53.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
1/31/2019ArgusUpgradeHold ➝ Buy$55.00Medium
i
1/31/2019Credit Suisse GroupUpgradeNeutral ➝ OutperformMedium
i
Rating by Vamil Divan at Credit Suisse Group AG
1/28/2019Credit Suisse GroupReiterated RatingNeutral$45.00High
i
Rating by Vamil Divan at Credit Suisse Group AG
1/23/2019UBS GroupDowngradeBuy ➝ NeutralLow
i
1/1/2019Credit Suisse GroupSet Price TargetNeutral$45.00Medium
i
Rating by Vamil Divan at Credit Suisse Group AG
12/30/2018Cantor FitzgeraldSet Price TargetBuy$53.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
12/26/2018Credit Suisse GroupSet Price TargetNeutral$45.00High
i
Rating by Vamil Divan at Credit Suisse Group AG
12/20/2018Credit Suisse GroupReiterated RatingNeutral$45.00Low
i
Rating by Vamil Divan at Credit Suisse Group AG
12/13/2018Credit Suisse GroupSet Price TargetHold$45.00Medium
i
Rating by Vamil Divan at Credit Suisse Group AG
12/11/2018Cantor FitzgeraldReiterated RatingBuy$53.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
12/11/2018JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$46.00Low
i
Rating by Chris Schott at JPMorgan Chase & Co.
11/27/2018Atlantic SecuritiesReiterated RatingBuy$54.00Medium
i
11/26/2018Credit Suisse GroupSet Price TargetHold$42.00Medium
i
Rating by Vamil Divan at Credit Suisse Group AG
11/19/2018Cantor FitzgeraldReiterated RatingBuy$53.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
11/8/2018Cantor FitzgeraldSet Price TargetBuy$53.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
11/6/2018CitigroupBoost Price TargetSell ➝ Sell$34.00 ➝ $37.00Medium
i
11/1/2018BMO Capital MarketsDowngradeOutperform ➝ Market Perform$47.00 ➝ $46.00Medium
i
11/1/2018Societe GeneraleSet Price TargetHold$43.00Medium
i
Rating by Florent Cespedes at Societe Generale
10/30/2018Credit Suisse GroupReiterated RatingNeutral ➝ Neutral$40.00Low
i
Rating by Vamil Divan at Credit Suisse Group AG
10/30/2018Goldman Sachs GroupReiterated RatingNeutral$45.00Low
i
10/30/2018JPMorgan Chase & Co.Reiterated RatingBuyLow
i
Rating by Chris Schott at JPMorgan Chase & Co.
10/23/2018Wolfe ResearchInitiated CoverageMarket PerformLow
i
10/19/2018BarclaysSet Price TargetNeutral$40.00Low
i
10/17/2018Cantor FitzgeraldReiterated RatingBuy$53.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
10/14/2018Credit Suisse GroupSet Price TargetHold$40.00Low
i
Rating by Vamil Divan at Credit Suisse Group AG
10/9/2018MorningstarSet Price TargetNeutral$46.00Low
i
10/4/2018Cantor FitzgeraldSet Price TargetBuy$45.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
10/4/2018Independent ResearchSet Price TargetNeutral$48.00Low
i
10/1/2018JPMorgan Chase & Co.Set Price TargetBuy$46.00Low
i
Rating by Chris Schott at JPMorgan Chase & Co.
9/27/2018MorningstarSet Price TargetBuy$46.00Low
i
9/26/2018BarclaysReiterated RatingNeutral$40.00Low
i
9/26/2018Cantor FitzgeraldSet Price TargetBuy$45.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
9/13/2018Morgan StanleySet Price TargetBuy$45.00Medium
i
Rating by David Risinger at Morgan Stanley
9/13/2018Cantor FitzgeraldSet Price TargetBuy$45.00Medium
i
Rating by Louise Chen at Cantor Fitzgerald
9/10/2018JPMorgan Chase & Co.Set Price TargetBuy$42.00Medium
i
9/7/2018BMO Capital MarketsBoost Price TargetOutperform$47.00Medium
i
Rating by Alex Arfaei at BMO Capital Markets
9/6/2018Credit Suisse GroupSet Price TargetHold$40.00Low
i
Rating by Vamil Divan at Credit Suisse Group AG
9/6/2018Morgan StanleySet Price TargetBuy$45.00Low
i
Rating by David Risinger at Morgan Stanley
8/29/2018BarclaysSet Price TargetNeutral$40.00Low
i
8/29/2018Morgan StanleySet Price TargetBuy$45.00Low
i
Rating by David Risinger at Morgan Stanley
8/28/2018Credit Suisse GroupSet Price TargetNeutral$40.00Low
i
Rating by Vamil Divan at Credit Suisse Group AG
8/28/2018Goldman Sachs GroupReiterated RatingNeutral$45.00Low
i
8/28/2018MorningstarSet Price TargetBuy$46.00Low
i
8/27/2018BMO Capital MarketsReiterated RatingBuy$44.00Low
i
Rating by Alex Arfaei at BMO Capital Markets
8/27/2018Cantor FitzgeraldSet Price TargetBuy$45.00High
i
Rating by Louise Chen at Cantor Fitzgerald
8/23/2018JPMorgan Chase & Co.Reiterated RatingBuy$42.00Low
i
8/23/2018BarclaysBoost Price TargetEqual Weight ➝ Neutral$38.00 ➝ $40.00Low
i
8/23/2018Morgan StanleySet Price TargetOverweight ➝ Buy$43.00 ➝ $45.00Low
i
Rating by David Risinger at Morgan Stanley
8/21/2018Deutsche Bank AktiengesellschaftSet Price TargetBuy$42.00 ➝ $45.00Low
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
8/13/2018Cantor FitzgeraldSet Price TargetBuy$45.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
8/10/2018SunTrust BanksBoost Price TargetHold$41.00Low
i
8/8/2018MorningstarSet Price TargetBuy$45.00Low
i
8/1/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$42.00 ➝ $43.00Low
i
8/1/2018Goldman Sachs GroupReiterated RatingNeutral$42.00Low
i
8/1/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$42.00 ➝ $44.00Medium
i
Rating by Alex Arfaei at BMO Capital Markets
8/1/2018Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$39.00 ➝ $40.00Medium
i
Rating by Vamil Divan at Credit Suisse Group AG
7/31/2018Jefferies Financial GroupSet Price TargetNeutral$39.00High
i
Rating by Ian Hilliker at Jefferies Financial Group Inc.
7/31/2018JPMorgan Chase & Co.Reiterated RatingBuyHigh
i
7/31/2018Credit Suisse GroupSet Price TargetHold$39.00High
i
7/31/2018Cantor FitzgeraldSet Price TargetBuy$45.00High
i
Rating by Louise Chen at Cantor Fitzgerald
7/19/2018BMO Capital MarketsReiterated RatingBuy$42.00Low
i
Rating by Alex Arfaei at BMO Capital Markets
7/18/2018JPMorgan Chase & Co.Reiterated Rating$37.66Medium
i
7/18/2018Cantor FitzgeraldSet Price TargetBuy$45.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
7/15/2018Jefferies Financial GroupSet Price TargetHold$39.00Low
i
Rating by Ian Hilliker at Jefferies Financial Group Inc.
7/12/2018Credit Suisse GroupSet Price TargetNeutral$39.00Low
i
7/11/2018Cantor FitzgeraldSet Price TargetBuy$45.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
7/11/2018JPMorgan Chase & Co.Reiterated RatingBuy$42.00Low
i
7/9/2018Jefferies Financial GroupReiterated RatingNeutral$39.00Medium
i
Rating by Ian Hilliker at Jefferies Financial Group Inc.
6/13/2018Cantor FitzgeraldSet Price TargetBuy$45.00Low
i
Rating by L. Chen at Cantor Fitzgerald
6/11/2018Morgan StanleyReiterated RatingBuy$43.00Low
i
6/11/2018Credit Suisse GroupSet Price TargetNeutral$39.00Low
i
6/7/2018Cantor FitzgeraldInitiated CoverageOverweight$45.00Low
i
Rating by L. Chen at Cantor Fitzgerald
5/30/2018Societe GeneraleReiterated RatingNeutral$39.00Low
i
5/18/2018Credit Suisse GroupReiterated RatingNeutral$39.00Low
i
5/14/2018Jefferies Financial GroupReiterated RatingNeutral$39.00Low
i
Rating by Ian Hilliker at Jefferies Financial Group Inc.
5/8/2018JPMorgan Chase & Co.Set Price TargetBuy$42.00Low
i
5/3/2018DZ BankReiterated RatingSellLow
i
5/2/2018MorningstarSet Price TargetBuy$43.50Low
i
5/2/2018BMO Capital MarketsLower Price TargetOutperform ➝ Outperform$43.00 ➝ $42.00Low
i
Rating by Alex Arfaei at BMO Capital Markets
5/2/2018JPMorgan Chase & Co.Reiterated RatingBuy$42.00Medium
i
4/13/2018Jefferies Financial GroupSet Price TargetHold$38.00Low
i
Rating by Ian Hilliker at Jefferies Financial Group Inc.
4/12/2018CitigroupReiterated RatingSellMedium
i
Rating by Andrew Baum at Citigroup Inc.
4/11/2018Berenberg BankReiterated RatingNeutral$37.00Low
i
4/5/2018BarclaysDowngradeOverweight ➝ Equal Weight$41.00 ➝ $38.00Medium
i
4/2/2018BMO Capital MarketsSet Price TargetBuy$43.00Medium
i
Rating by Alex Arfaei at BMO Capital Markets
3/6/2018BMO Capital MarketsSet Price TargetBuy$43.00Low
i
Rating by Alex Arfaei at BMO Capital Markets
2/26/2018Jefferies Financial GroupSet Price TargetHold$39.00Low
i
Rating by Ian Hilliker at Jefferies Financial Group Inc.
2/15/2018BMO Capital MarketsSet Price TargetBuy$43.00Low
i
Rating by Alex Arfaei at BMO Capital Markets
2/5/2018BMO Capital MarketsSet Price TargetBuy$43.00High
i
Rating by Alex Arfaei at BMO Capital Markets
1/31/2018BarclaysBoost Price TargetOverweight ➝ Overweight$38.00 ➝ $41.00Medium
i
1/31/2018Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$37.00 ➝ $39.00Medium
i
1/31/2018SVB LeerinkBoost Price TargetMarket Perform ➝ Market Perform$35.00 ➝ $38.00Medium
i
1/31/2018UBS GroupSet Price TargetBuy$42.00Medium
i
Rating by Marc Goodman at UBS Group AG
1/31/2018Morgan StanleyBoost Price TargetOverweight ➝ Buy$41.00 ➝ $43.00Medium
i
1/31/2018Societe GeneraleSet Price TargetNeutral$40.00Medium
i
1/30/2018Goldman Sachs GroupSet Price TargetNeutral$36.00High
i
1/30/2018MorningstarSet Price TargetNeutral$38.00High
i
1/30/2018Bank of AmericaSet Price TargetBuy$40.00Medium
i
Rating by Jason Gerberry at Bank of America Co.
1/30/2018JPMorgan Chase & Co.Reiterated RatingBuyLow
i
1/30/2018Sanford C. BernsteinSet Price TargetBuy$43.00Low
i
1/30/2018Berenberg BankSet Price TargetNeutral$36.00Low
i
1/30/2018BMO Capital MarketsSet Price TargetBuy$39.00High
i
Rating by Alex Arfaei at BMO Capital Markets
1/29/2018SunTrust BanksReiterated RatingHold ➝ Hold$33.00 ➝ $40.00Low
i
1/24/2018BMO Capital MarketsSet Price TargetBuy$39.00Low
i
Rating by Alex Arfaei at BMO Capital Markets
1/16/2018Jefferies Financial GroupSet Price TargetNeutral$40.00Low
i
1/8/2018BMO Capital MarketsSet Price TargetBuy$39.00Low
i
Rating by Alex Arfaei at BMO Capital Markets
1/5/2018Morgan StanleySet Price TargetBuy$41.00Low
i
1/2/2018Nord/LBReiterated RatingNeutralLow
i
12/27/2017Nord/LBReiterated RatingNeutralLow
i
12/15/2017BMO Capital MarketsSet Price TargetBuy$39.00Low
i
Rating by Alex Arfaei at BMO Capital Markets
12/8/2017BMO Capital MarketsSet Price TargetBuy$39.00Low
i
Rating by Alex Arfaei at BMO Capital Markets
12/6/2017UBS GroupSet Price TargetBuy$40.00Low
i
Rating by Marc Goodman at UBS Group AG
12/6/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy$38.00Low
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
11/25/2017BMO Capital MarketsSet Price TargetBuy$39.00Low
i
Rating by Alex Arfaei at BMO Capital Markets
11/16/2017Jefferies Financial GroupSet Price TargetNeutral$39.00N/A
i
11/10/2017BMO Capital MarketsReiterated RatingBuy$39.00N/A
i
Rating by Alex Arfaei at BMO Capital Markets
11/1/2017JPMorgan Chase & Co.Set Price TargetBuy$39.00N/A
i
11/1/2017Jefferies Financial GroupSet Price TargetNeutral$39.00N/A
i
11/1/2017Goldman Sachs GroupSet Price TargetNeutral$36.00N/A
i
11/1/2017UBS GroupSet Price TargetBuy$38.00N/A
i
Rating by Marc Goodman at UBS Group AG
10/31/2017Berenberg BankSet Price TargetNeutral$36.00N/A
i
10/31/2017BMO Capital MarketsSet Price TargetBuy$39.00N/A
i
Rating by Alex Arfaei at BMO Capital Markets
10/26/2017Jefferies Financial GroupSet Price TargetNeutral$39.00N/A
i
10/19/2017BMO Capital MarketsReiterated RatingBuy$37.00 ➝ $39.00N/A
i
Rating by Alex Arfaei at BMO Capital Markets
10/16/2017Jefferies Financial GroupSet Price TargetNeutral$38.00N/A
i
10/11/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy$38.00N/A
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
10/11/2017BarclaysSet Price TargetBuy$38.00N/A
i
10/10/2017BMO Capital MarketsSet Price TargetBuy$37.00N/A
i
Rating by Alex Arfaei at BMO Capital Markets
9/20/2017Morgan StanleyUpgradeEqual Weight ➝ Overweight$35.00 ➝ $39.00Low
i
9/19/2017Sanford C. BernsteinSet Price TargetBuy$39.00Low
i
9/18/2017Jefferies Financial GroupSet Price TargetNeutral$37.00Low
i
9/14/2017BMO Capital MarketsReiterated RatingBuy$37.00High
i
Rating by Alex Arfaei at BMO Capital Markets
9/6/2017BMO Capital MarketsReiterated RatingBuy$37.00Low
i
Rating by Alex Arfaei at BMO Capital Markets
8/24/2017Jefferies Financial GroupSet Price TargetNeutral$35.00Low
i
8/18/2017Jefferies Financial GroupReiterated RatingHold$35.00Low
i
8/15/2017Berenberg BankReiterated RatingHold$39.00 ➝ $36.00Low
i
8/14/2017CowenSet Price TargetBuy$43.00Low
i
Rating by Steve Scala at Cowen Inc
8/2/2017Jefferies Financial GroupSet Price TargetNeutral$35.00Low
i
8/2/2017BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$33.00 ➝ $37.00Low
i
Rating by Alex Arfaei at BMO Capital Markets
8/1/2017Berenberg BankSet Price TargetNeutral$39.00Low
i
7/31/2017UBS GroupReiterated RatingBuy$38.00Medium
i
7/20/2017Credit Suisse GroupDowngradeOutperform ➝ Neutral$38.00 ➝ $36.00Low
i
7/17/2017Sanford C. BernsteinSet Price TargetBuy$39.00Low
i
7/14/2017Jefferies Financial GroupReiterated RatingHold$34.00 ➝ $35.00Low
i
7/10/2017CowenSet Price TargetBuy$43.00Low
i
Rating by Steve Scala at Cowen Inc
6/16/2017Jefferies Financial GroupReiterated RatingNeutral$34.00Low
i
6/12/2017Morgan StanleyReiterated RatingNeutral$38.00 ➝ $35.00Low
i
5/16/2017CitigroupDowngradeNeutral ➝ Sell$38.00 ➝ $31.00Low
i
5/3/2017BarclaysReiterated RatingBuy$38.00Low
i
5/3/2017Sanford C. BernsteinReiterated RatingBuy$37.00Low
i
4/27/2017BMO Capital MarketsReiterated RatingHold$33.00Low
i
Rating by Alex Arfaei at BMO Capital Markets
4/24/2017Sanford C. BernsteinReiterated RatingBuy$35.00Low
i
4/13/2017Jefferies Financial GroupReiterated RatingNeutral$34.00 ➝ $35.00Low
i
4/6/2017Morgan StanleyReiterated RatingNeutral$38.00Low
i
3/24/2017Sanford C. BernsteinReiterated RatingBuy$35.00Low
i
3/23/2017Societe GeneraleReiterated RatingNeutral$36.00Low
i
3/21/2017BMO Capital MarketsReiterated RatingHold$33.00Low
i
Rating by Alex Arfaei at BMO Capital Markets
3/16/2017BarclaysSet Price TargetBuy$38.00Low
i
3/14/2017UBS GroupReiterated RatingBuy$38.00N/A
i
Rating by Marc Goodman at UBS Group AG
3/13/2017Sanford C. BernsteinSet Price TargetBuy$35.00Low
i
3/13/2017Credit Suisse GroupSet Price TargetBuy$38.00Low
i
3/9/2017Jefferies Financial GroupSet Price TargetNeutral$34.00Low
i
2/17/2017Jefferies Financial GroupSet Price TargetNeutral$34.00N/A
i
2/17/2017Berenberg BankSet Price TargetNeutral$39.00N/A
i
2/16/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$40.00N/A
i
2/2/2017MorningstarReiterated RatingBuyN/A
i
2/1/2017Atlantic SecuritiesSet Price TargetBuy$37.00N/A
i
1/30/2017BMO Capital MarketsReiterated RatingMarket Perform$33.00N/A
i
Rating by Alex Arfaei at BMO Capital Markets
1/24/2017Sanford C. BernsteinSet Price TargetBuy$35.00N/A
i
1/21/2017Piper Jaffray CompaniesSet Price TargetBuy$53.00N/A
i
Rating by Richard Purkiss at Piper Jaffray Companies
1/19/2017Jefferies Financial GroupReiterated RatingHold$30.00N/A
i
1/18/2017Goldman Sachs GroupSet Price TargetNeutral$36.00N/A
i
12/20/2016Credit Suisse GroupReiterated RatingBuy$38.00N/A
i
12/19/2016Jefferies Financial GroupReiterated RatingHold$30.00N/A
i
Rating by Jeffrey Holford at Jefferies Financial Group Inc.
12/7/2016Sanford C. BernsteinReiterated RatingOverweightN/A
i
12/2/2016GuggenheimInitiated CoverageNeutralN/A
i
11/30/2016BMO Capital MarketsSet Price TargetHold$33.00N/A
i
Rating by Alex Arfaei at BMO Capital Markets
11/29/2016BarclaysUpgradeEqual Weight ➝ Overweight$38.00N/A
i
11/11/2016Jefferies Financial GroupSet Price TargetNeutral$34.00N/A
i
Rating by Jeffrey Holford at Jefferies Financial Group Inc.
11/7/2016Bank of AmericaReiterated RatingBuy$40.00 ➝ $36.00N/A
i
Rating by colin bristow at Bank of America Co.
11/3/2016Atlantic SecuritiesSet Price TargetBuy$35.00N/A
i
11/2/2016ArgusDowngradeBuy ➝ HoldN/A
i
Rating by jacob kilstein at Argus
11/2/2016BMO Capital MarketsDowngradeOutperform ➝ Market Perform$40.00 ➝ $33.00N/A
i
11/1/2016Berenberg BankSet Price TargetNeutral$38.00N/A
i
Rating by Alistair Campbell at Berenberg Bank
11/1/2016Sanford C. BernsteinSet Price TargetBuy$36.00N/A
i
10/19/2016Sanford C. BernsteinSet Price TargetBuy$36.00N/A
i
10/18/2016BMO Capital MarketsReiterated RatingOutperform$40.00N/A
i
Rating by Alex Arfaei at BMO Capital Markets
10/13/2016Jefferies Financial GroupDowngradeBuy ➝ Hold$39.00 ➝ $36.00N/A
i
Rating by Jeffrey Holford at Jefferies Financial Group Inc.
10/4/2016ArgusReiterated RatingBuy$39.00N/A
i
Rating by jacob kilstein at Argus
9/30/2016UBS GroupSet Price TargetBuy$38.00N/A
i
Rating by Steven Milunovich at UBS Group AG
9/27/2016Bank of AmericaReiterated RatingBuy$40.00N/A
i
Rating by colin bristow at Bank of America Co.
9/26/2016Sanford C. BernsteinReiterated RatingOutperformN/A
i
Rating by Tim Anderson at Sanford C. Bernstein
9/13/2016Jefferies Financial GroupLower Price TargetBuy$40.00 ➝ $39.00N/A
i
Rating by Jeffrey Holford at Jefferies Financial Group Inc.
9/7/2016UBS GroupReiterated RatingBuyN/A
i
Rating by Steven Milunovich at UBS Group AG
8/28/2016ArgusReiterated RatingBuy$39.00N/A
i
Rating by jacob kilstein at Argus
8/25/2016Jefferies Financial GroupSet Price TargetBuy$40.00N/A
i
Rating by Jeffrey Holford at Jefferies Financial Group Inc.
8/23/2016Piper Jaffray CompaniesSet Price TargetBuy$54.00N/A
i
Rating by richard purkiss at Piper Jaffray Companies
8/23/2016BMO Capital MarketsReiterated RatingOutperform$40.00N/A
i
Rating by Alex Arfaei at BMO Capital Markets
8/22/2016Bank of AmericaSet Price TargetBuy$40.00N/A
i
Rating by colin bristow at Bank of America Co.
8/22/2016Credit Suisse GroupReiterated RatingOutperform$40.00N/A
i
8/18/2016Deutsche Bank AktiengesellschaftReiterated RatingBuy$44.00N/A
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
8/3/2016JPMorgan Chase & Co.Set Price TargetBuy$40.00N/A
i
Rating by Chris Schott at JPMorgan Chase & Co.
8/3/2016CitigroupReiterated RatingNeutral$37.00N/A
i
8/2/2016BarclaysReiterated RatingEqual Weight$34.00N/A
i
8/2/2016Sanford C. BernsteinSet Price TargetBuy$38.00N/A
i
Rating by Tim Anderson at Sanford C. Bernstein
8/1/2016Jefferies Financial GroupSet Price TargetBuy$41.50 ➝ $40.00N/A
i
Rating by Jeffrey Holford at Jefferies Financial Group Inc.
7/25/2016Piper Jaffray CompaniesSet Price TargetBuy$54.00N/A
i
Rating by Richard Purkiss at Piper Jaffray Companies
7/25/2016JPMorgan Chase & Co.Set Price TargetBuy$40.00N/A
i
Rating by Chris Schott at JPMorgan Chase & Co.
7/21/2016BMO Capital MarketsReiterated RatingBuy$40.00N/A
i
Rating by Alex Arfaei at BMO Capital Markets
7/14/2016Jefferies Financial GroupSet Price TargetBuy$40.00 ➝ $41.50N/A
i
Rating by Jeffrey Holford at Jefferies Financial Group Inc.
6/27/2016Piper Jaffray CompaniesReiterated RatingOverweight$54.00N/A
i
6/20/2016Jefferies Financial GroupLower Price TargetBuy$42.00 ➝ $40.00N/A
i
Rating by Jeffrey Holford at Jefferies Financial Group Inc.
6/15/2016Deutsche Bank AktiengesellschaftReiterated RatingBuyN/A
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
6/14/2016Jefferies Financial GroupReiterated RatingBuy$41.00 ➝ $42.00N/A
i
Rating by Jeffrey Holford at Jefferies Financial Group Inc.
5/19/2016JPMorgan Chase & Co.Reiterated RatingOverweightN/A
i
Rating by Chris Schott at JPMorgan Chase & Co.
5/17/2016Morgan StanleyReiterated RatingHold$36.00N/A
i
Rating by David Risinger at Morgan Stanley
5/12/2016Berenberg BankInitiated CoverageHold$38.00N/A
i
5/11/2016Jefferies Financial GroupSet Price TargetBuy$41.00N/A
i
Rating by Jeffrey Holford at Jefferies Financial Group Inc.
5/10/2016Bank of AmericaReiterated RatingBuy$38.48 ➝ $28.25N/A
i
Rating by Colin Bristow at Bank of America Co.
5/10/2016UBS GroupSet Price TargetBuy$38.00N/A
i
Rating by Steven Milunovich at UBS Group AG
5/9/2016Goldman Sachs GroupSet Price TargetNeutral$37.00N/A
i
5/9/2016Morgan StanleySet Price TargetNeutral$36.00N/A
i
Rating by David Risinger at Morgan Stanley
5/9/2016Credit Suisse GroupBoost Price TargetOutperform$38.00 ➝ $39.00N/A
i
5/4/2016BMO Capital MarketsReiterated RatingBuy$39.00 ➝ $40.00N/A
i
Rating by Alex Arfaei at BMO Capital Markets
5/4/2016UBS GroupBoost Price TargetBuy$36.00 ➝ $38.00N/A
i
5/4/2016Independent ResearchSet Price TargetNeutral$37.00N/A
i
5/4/2016Societe GeneraleSet Price TargetNeutral$34.00N/A
i
5/3/2016Sanford C. BernsteinSet Price TargetBuy$36.00N/A
i
Rating by Tim Anderson at Sanford C. Bernstein
5/2/2016SVB LeerinkLower Price TargetMarket Perform$37.00 ➝ $34.70N/A
i
Rating by Jason Gerberry at SVB Leerink LLC
4/28/2016BMO Capital MarketsReiterated RatingBuyN/A
i
4/18/2016Goldman Sachs GroupReiterated RatingNeutral$35.00N/A
i
4/12/2016S&P Equity ResearchReiterated RatingBuyN/A
i
Rating by Jeffrey Loo at S&P Equity Research
4/7/2016Independent ResearchSet Price TargetNeutral$35.00N/A
i
4/7/2016Morgan StanleyInitiated CoverageOverweight ➝ Equal Weight$35.00N/A
i
4/7/2016JPMorgan Chase & Co.Initiated CoverageOverweight$38.00N/A
i
4/6/2016Societe GeneraleInitiated CoverageHold$33.00N/A
i
4/5/2016BMO Capital MarketsReiterated RatingOutperform$39.00N/A
i
4/5/2016SVB LeerinkReiterated RatingHoldN/A
i
Rating by Jason Gerberry at SVB Leerink LLC
4/5/2016Jefferies Financial GroupReiterated RatingBuy$42.00 ➝ $39.00N/A
i
4/5/2016Sanford C. BernsteinReiterated RatingBuy$36.00N/A
i
3/20/2016Piper Jaffray CompaniesReiterated RatingOverweight$54.00N/A
i
Rating by Richard Purkiss at Piper Jaffray Companies
3/8/2016Jefferies Financial GroupReiterated RatingBuy$45.00 ➝ $42.00N/A
i
2/22/2016Jefferies Financial GroupLower Price TargetBuy$45.00N/A
i
2/16/2016SunTrust BanksLower Price TargetNeutral$37.00 ➝ $33.00N/A
i
Rating by John Boris at SunTrust Banks, Inc.
2/11/2016ArgusBoost Price TargetBuy$32.00 ➝ $39.00N/A
i
2/10/2016Deutsche Bank AktiengesellschaftReiterated RatingBuyN/A
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
2/9/2016Bank of AmericaUpgradeBuy ➝ Top Pick$39.00N/A
i
2/5/2016Credit Suisse GroupLower Price Target$41.00 ➝ $38.00N/A
i
2/5/2016Piper Jaffray CompaniesReiterated RatingOverweight$23.00N/A
i
Rating by Richard Purkiss at Piper Jaffray Companies
2/3/2016Independent ResearchSet Price TargetNeutral$34.00N/A
i
2/3/2016Deutsche Bank AktiengesellschaftLower Price TargetBuy$43.00 ➝ $41.00N/A
i
2/3/2016Sanford C. BernsteinLower Price TargetOutperform$41.00 ➝ $36.00N/A
i
2/3/2016BMO Capital MarketsReiterated RatingOutperform$41.00 ➝ $39.00N/A
i
1/26/2016Nord/LBReiterated RatingBuyN/A
i
1/15/2016UBS GroupSet Price TargetBuy$36.00N/A
i
1/14/2016Jefferies Financial GroupLower Price TargetBuy$48.00 ➝ $45.00N/A
i
1/5/2016BarclaysReiterated RatingNeutral$34.00N/A
i
Rating by Geoff Meacham at Barclays PLC
1/5/2016Atlantic SecuritiesReiterated RatingBuy$39.00N/A
i
12/30/2015Atlantic SecuritiesSet Price TargetBuy$39.00N/A
i
12/24/2015Atlantic SecuritiesSet Price TargetBuy$39.00N/A
i
12/18/2015Atlantic SecuritiesInitiated CoverageOverweight$39.00N/A
i
12/7/2015Jefferies Financial GroupBoost Price TargetBuy$48.00N/A
i
Rating by Jeffrey Holford at Jefferies Financial Group Inc.
12/2/2015CowenReiterated RatingBuy$43.00N/A
i
Rating by Steve Scala at Cowen Inc
12/2/2015SunTrust BanksUpgradeHoldN/A
i
Rating by John Boris at SunTrust Banks, Inc.
12/1/2015BarclaysInitiated CoverageEqual Weight$34.00N/A
i
11/25/2015Credit Suisse GroupReiterated RatingOutperform$41.00N/A
i
11/25/2015SunTrust BanksUpgradeReduce ➝ Neutral$34.00 ➝ $37.00N/A
i
Rating by John Boris at SunTrust Banks, Inc.
11/24/2015Jefferies Financial GroupSet Price TargetBuy$47.00N/A
i
Rating by Jeffrey Holford at Jefferies Financial Group Inc.
11/24/2015Evercore ISIReiterated RatingBuy$38.00N/A
i
11/23/2015CowenReiterated RatingOutperform$43.00N/A
i
Rating by Steve Scala at Cowen Inc
11/23/2015Sanford C. BernsteinSet Price TargetBuy$41.00N/A
i
11/20/2015Independent ResearchReiterated RatingNeutral$36.00N/A
i
11/15/2015Piper Jaffray CompaniesReiterated RatingBuyN/A
i
Rating by Benji Star at Piper Jaffray Companies
11/3/2015ArgusBoost Price TargetBuy$41.00 ➝ $46.00N/A
i
11/2/2015JPMorgan Chase & Co.Boost Price TargetOutperform$36.00 ➝ $38.00N/A
i
11/2/2015CowenBoost Price TargetMarket Perform$34.00 ➝ $35.00N/A
i
Rating by Steve Scala at Cowen Inc
11/1/2015JPMorgan Chase & Co.Reiterated RatingOverweight$40.00N/A
i
11/1/2015Credit Suisse GroupBoost Price TargetOutperform$40.00 ➝ $41.00N/A
i
10/28/2015Independent ResearchReiterated RatingNeutral$38.00N/A
i
10/28/2015S&P Equity ResearchReiterated RatingHold$40.00N/A
i
10/28/2015Deutsche Bank AktiengesellschaftBoost Price TargetBuy$41.00 ➝ $43.00N/A
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
10/28/2015Sanford C. BernsteinBoost Price TargetOutperform$40.00 ➝ $41.00N/A
i
10/27/2015CowenReiterated RatingBuy$43.00N/A
i
Rating by Sharon Stein at Cowen Inc
(Data available from 10/23/2015 forward)
Pfizer logo
Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases under the Lyrica, Chantix/Champix, Eliquis, Ibrance, Sutent, Xalkori, Inlyta, Xtandi, Enbrel, Xeljanz, Eucrisa, BeneFix, Genotropin, and Refacto AF/Xyntha brands. The company also provides consumer healthcare products that comprise over-the-counter medicines, including dietary supplement products under the Centrum, Caltrate, and Emergen-C names; pain management products under the Advil and ThermaCare names; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H names; and respiratory and personal care products under the Robitussin, Advil Cold & Sinus, and ChapStick names. In addition, it offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit, Ixifi Infliximab BS names. Further, the company is also involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., and Merck KGaA; licensing agreement with BionTech AG; and collaboration agreements with Merck & Co., Inc. and Eli Lilly & Company, as well as with Merck KGaA and Nektar Therapeutics to develop a therapy for treating pancreatic cancer. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Read More

Today's Range

Now: $38.18
$37.65
$38.29

50 Day Range

MA: $36.59
$35.65
$37.95

52 Week Range

Now: $38.18
$27.88
$40.97

Volume

28,919,286 shs

Average Volume

20,809,482 shs

Market Capitalization

$212.16 billion

P/E Ratio

15.15

Dividend Yield

4.02%

Beta

0.66